Weight loss Injections Mounjaro (Tirzepatide)
Why are Diabetes Medications Used for Weight Loss?
Certain medications used for diabetes treatment have shown potential for weight loss due to their effects on blood glucose levels and insulin sensitivity. These medications mimic the GLP-1 hormone and some also target the GIP hormone to decrease appetite.
The GLP-1 hormone, released after meals, stimulates insulin release, slows sugar release from the liver, delays digestion, and promotes a feeling of fullness.
The GIP hormone signals the brain from the gut, triggering thoughts of food and cravings.
Ozempic and Wegovy, both versions of semaglutide, have gained attention on platforms like TikTok, where celebrities endorse their weight loss effects. These drugs mimic the GLP-1 hormone.
What sets Mounjaro apart from other insulin medications is its ability to target both hormones, resulting in decreased appetite, fewer cravings, and reduced hunger.
This unique mechanism has been shown to increase weight loss and help patients achieve an A1c level below 7.0 percent. A1c is a significant blood test that indicates average blood sugar levels without the daily fluctuations.
How is Mounjaro administered?
Mounjaro is injected once a week subcutaneously in the abdomen, thighs, or back of the upper arms. It is similar to insulin administration but should not be mixed with insulin in the same injection, as advised by the manufacturer.
Side effects
Like most medications, Mounjaro has potential side effects. It is available in different doses: 2.5 mg, 5 mg, 10 mg, or 15 mg. Starting with a lower dose and gradually increasing may help reduce side effects. Commonly reported side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, indigestion, stomach pain, and low blood sugar (hypoglycemia).
Uncommon but more severe side effects may include pancreatitis, gallbladder issues, or thyroid tumors/cancer.
Mounjaro (Tirzepatide) vs. Semaglutide - Which is better?
A comparison of these two diabetes medications showed that tirzepatide (Mounjaro) outperformed semaglutide in controlling blood sugar, lowering A1c, reducing triglycerides and lipoproteins, and promoting weight loss. Side effects were typically dose-dependent, and starting with a lower dose was associated with milder symptoms. Gastric-related side effects were reported to be less severe with Mounjaro compared to semaglutide.
The Bottom Line - What does this mean for weight loss?
While diet and exercise alone typically lead to a 5% reduction in body weight, using weight loss drugs like Mounjaro can increase weight loss to more than three times that amount. In a 72-week study on obesity, Mounjaro demonstrated sustained weight loss throughout the study period, and the amount of weight lost correlated with the medication dose.
This significant weight loss has the potential to revolutionize healthcare, as obesity is a disease that requires treatment. When overweight patients develop diabetes, the challenge of weight loss becomes even more complex.
The Future of Weight Loss Injections
With medications available to suppress appetite, increase insulin release, and slow digestion, we now have the potential to positively impact the lives of millions. In addition to weight loss, there is a possibility of reducing or eliminating medical conditions such as high blood pressure, heart disease, and acid reflux.
Some industry experts predict that Mounjaro could become one of the best-selling drugs of all time.
Buy Mounjaro Online?
Mounjaro will be available to buy in the UK soon, signup to receive an email alert.